Average Co-Inventor Count = 7.88
ph-index = 24
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Abbott Biotechnology Ltd. (8 from 17 patents)
2. Basf Aktiengesellschaft (7 from 10,754 patents)
3. Abbott Gmbh & Co Kg (5 from 140 patents)
4. Abbvie Inc. (4 from 823 patents)
5. Abbvie Biotechnology Ltd (4 from 93 patents)
6. Abbott Laboratories Corporation (3 from 4,180 patents)
7. Knoll Aktiengesellschaft (2 from 84 patents)
8. Other (1 from 833,002 patents)
9. Abbvie Deutschland Gmbh and Co Kg (1 from 167 patents)
33 patents:
1. 9226983 - TNF-α binding proteins
2. 9090689 - Use of TNFα inhibitor for treatment of psoriasis
3. 9085620 - Use of TNFα inhibitor for treatment of psoriatic arthritis
4. 9046513 - Dual variable domain immunoglobulins and uses thereof
5. 9035030 - Human antibodies that bind the P40 subunit of human IL-12 and methods for using the same
6. 8906373 - Use of TNF-alpha inhibitor for treatment of psoriasis
7. 8865174 - Methods of treatment using human antibodies that bind IL-12
8. 8765918 - Human antibodies that bind human interleukin-12
9. 8753633 - Human antibodies that bind human TNFα
10. 8722855 - Dual variable domain immunoglobulins and uses thereof
11. 8414894 - Human antibodies that bind human TNFα and methods of using same
12. 8372401 - Human antibodies that bind human TNFα
13. 8372400 - Methods of treating disorders using human antibodies that bind human TNFα
14. 8258268 - Dual variable domain immunoglobulin and uses thereof
15. 8206714 - Methods for treating rheumatoid arthritis using human antibodies that bind human TNFa